Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
about
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel DiseaseColitis-associated colon cancer: Is it in your genes?Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalkSystemic causes of cholestasisContribution of gut bacteria to liver pathobiology.Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease.Pros and cons of medical management of ulcerative colitis.Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-a case series and review of the literatureDysregulated intrahepatic CD4(+) T-cell activation drives liver inflammation in ileitis-prone SAMP1/YitFc miceComparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn's diseasePNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel DiseaseCrohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis.Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.Ulcerative colitis and immunoglobulin G4.Hepatobiliary disorders and complications of inflammatory bowel disease.MR enterography findings in abdominopelvic extraintestinal complications of Crohn's disease.The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literatureExtraintestinal manifestations and complications in IBD.Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases.A systematic review of the evidence for central nervous system plasticity in animal models of inflammatory-mediated gastrointestinal pain.Gastrointestinal motility disorders in inflammatory bowel diseases.Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey.Pancreatitis and triaditis in cats: causes and treatment.Diagnosis and management of primary sclerosing cholangitis-perspectives from a therapeutic endoscopist.Pediatric inflammatory bowel disease: imaging issues with targeted solutions.Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.Pancreatic involvement in pediatric inflammatory bowel diseases.Dysplasia and colorectal cancer surveillance in inflammatory bowel disease.Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectives.Increased subsequent risk of inflammatory bowel disease association in patients with chronic pancreatitis: a nationwide population-based cohort study.Impact of Concurrent Non-IBD Immunological Diseases on the Outcome of Primary Sclerosing Cholangitis.Pyogenic liver abscess in patients with inflammatory bowel disease: a nationwide cohort study.Prevalence and prognostic value of hepatic histological alterations in patients with Crohn's disease.Gut Inflammation in Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis-Contrasting Pattern of Liver-gut Cross TalkNon-surgical porto-mesenteric vein thrombosis is associated with worse long-term outcomes in inflammatory bowel diseases.Primary sclerosing cholangitis and the risk of colon neoplasia in patients with Crohn's colitis.Liver disorders in inflammatory bowel disease.Chronic pancreatitis as presentation of Crohn's disease in a child
P2860
Q22241416-12C8FDCC-F976-4FAA-B096-6B100355D283Q26778018-999426F8-96FC-4524-A3EC-1D75E422824EQ26829300-DCB3F6E3-4D21-4656-AE01-F436FCD7E9AFQ27008041-7BE46AF7-AD60-4BF5-A915-207D741488FCQ34035372-22FFDCC7-B651-466A-9450-B79C0348A07CQ34396606-F80B2CFC-07FB-4DAB-87A2-5DB6D9F3A26AQ35100726-90B71063-F2D0-47A6-AB2B-92AF8E29F349Q35109416-58BDCB11-AB12-47D4-B143-E9C57BAFFC83Q35880725-4F5C1835-6EA9-486D-A258-A3EEE7502BB0Q36596777-CF17CB0D-5FFA-4003-BF5C-5BC7940674EFQ36973400-DB6F02A9-1CDE-41CA-BBEB-FF758CE866E4Q37098461-9EF3229B-94E9-4B05-A009-AD4B81D8806BQ37126766-4CCFE8E3-4EB5-430F-9DE1-8B6CBED851E8Q37317444-C667245D-DB0E-4D22-B129-4125626B4E5DQ37564017-925B81C9-6090-4BB5-ACDA-94B21FE72094Q37905969-7950D750-DC23-4874-9E37-37541728741BQ38051583-B052EA4B-53E1-4B34-BE3C-015EAE505FE7Q38055153-D458ED30-7EEB-4E32-9E9F-8F87E897AF1BQ38120146-58427931-6C78-412D-8011-7AED0F39E2E7Q38159685-1A14B370-795A-4574-A49C-C1717730BCD3Q38166887-9541DECF-61C8-4632-B149-3BFE8073F8C6Q38177780-CCC4E854-0D7D-487C-98E9-26921A16CFCAQ38210793-BC5CAE12-CE24-4D05-997E-6B97DC071050Q38223382-92002373-FB4D-42B3-A6C1-2743E5A38870Q38317628-364E34E1-8645-44D8-9450-CDBD1FC32846Q38443665-97CECD1A-F1B5-4A36-B6A8-925B5AE2C4FEQ38446635-A1BB4FAE-A9DC-4605-9EA1-53FFB5CE3DFEQ38496932-CC1DED7A-AF50-4F48-9D31-FF0F559B5A1CQ38562642-3ABB054E-F572-46B8-885B-825A1904DFD8Q38687411-D64DECB9-084F-4E54-8E59-F73F31F2599CQ38747656-C42D58EF-9213-4444-97F0-F21B5651FCB0Q38917833-1570B9CD-9C5A-445E-89B1-3317F1D5FB2BQ39942636-7864F4B9-E30C-4892-B157-C8E81DD4B892Q40900464-62DE98D4-868F-4189-B952-2A7D92D209AEQ41128473-B9FB93C9-02D7-4183-9B80-0559E2BEB1CEQ41879967-8382AFDE-C135-4CF4-B13D-D6DBCDFBB744Q42059567-8034EFC7-5940-4C3D-80EC-DE82BF319EB9Q42115115-78AE8EB4-E1FA-4C39-B9B4-22B75286C211Q42122089-531B4005-F743-4366-9482-DFB89F4A317CQ42559223-8074FDF7-269C-49BE-A5B6-4A44759DA4F8
P2860
Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatopancreatobiliary manifes ...... th inflammatory bowel disease.
@en
Hepatopancreatobiliary manifes ...... th inflammatory bowel disease.
@nl
type
label
Hepatopancreatobiliary manifes ...... th inflammatory bowel disease.
@en
Hepatopancreatobiliary manifes ...... th inflammatory bowel disease.
@nl
prefLabel
Hepatopancreatobiliary manifes ...... th inflammatory bowel disease.
@en
Hepatopancreatobiliary manifes ...... th inflammatory bowel disease.
@nl
P2860
P356
P1476
Hepatopancreatobiliary manifes ...... th inflammatory bowel disease.
@en
P2093
Udayakumar Navaneethan
P2860
P304
P356
10.1002/IBD.21219
P577
2010-09-01T00:00:00Z